Cargando…
Multicentre appraisal of amyotrophic lateral sclerosis biofluid biomarkers shows primacy of blood neurofilament light chain
The routine clinical integration of individualized objective markers of disease activity in those diagnosed with the neurodegenerative disorder amyotrophic lateral sclerosis is a key requirement for therapeutic development. A large, multicentre, clinic-based, longitudinal cohort was used to systemat...
Autores principales: | Thompson, Alexander G., Gray, Elizabeth, Verber, Nick, Bobeva, Yoana, Lombardi, Vittoria, Shepheard, Stephanie R., Yildiz, Ozlem, Feneberg, Emily, Farrimond, Lucy, Dharmadasa, Thanuja, Gray, Pamela, Edmond, Evan C., Scaber, Jakub, Gagliardi, Delia, Kirby, Janine, Jenkins, Thomas M., Fratta, Pietro, McDermott, Christopher J., Manohar, Sanjay G., Talbot, Kevin, Malaspina, Andrea, Shaw, Pamela J., Turner, Martin R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870425/ https://www.ncbi.nlm.nih.gov/pubmed/35224491 http://dx.doi.org/10.1093/braincomms/fcac029 |
Ejemplares similares
-
Humoral response to neurofilaments and dipeptide repeats in ALS progression
por: Puentes, Fabiola, et al.
Publicado: (2021) -
Genetic testing in motor neurone disease
por: Dharmadasa, Thanuja, et al.
Publicado: (2022) -
Limited value of serum neurofilament light chain in diagnosing amyotrophic lateral sclerosis
por: Davies, Jennifer C, et al.
Publicado: (2023) -
Creatine kinase and prognosis in amyotrophic lateral sclerosis: a literature review and multi-centre cohort analysis
por: Gao, Jiali, et al.
Publicado: (2022) -
Value of systematic genetic screening of patients with amyotrophic lateral sclerosis
por: Shepheard, Stephanie R, et al.
Publicado: (2021)